FierceBiotech's Amirah Al Idrus sits down with FiercePharma's Carly Helfand and Beth Snyder Bulik to discuss this year's #FierceMadness drug-name tournament. Which names are strong contenders? Which names evoke unappealing images? And, ultimately, which name will be the last one standing?
We also chat with Scott Piergrossi, vice president of creative development at Brand Institute, a branding and identity development company that worked on more than 80% of the drug names the FDA approved in 2017.
Check out the #FierceMadness matchups and download a bracket here. And download the episode on iTunes or Stitcher, or listen below—and be sure to subscribe. Let us know what you think by leaving a review or dropping us a line at radio@fiercebiotech.com.